BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026)
BioAge Labs (BIOA) posted Other Non-Current Assets of $215000.0 for Q1 2026, little changed sequentially from $216000.0 in Q4 2025, and down 10.04% YoY from $239000.0 in Q1 2025.
BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026) Analysis & Trends
BioAge Labs has reported Other Non-Current Assets for 4 years, with the latest figure at $215000.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 10.04% year-over-year to $215000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215000.0 (down 10.04% YoY) and the FY2025 annual result came in at $216000.0, down 10.0% from the prior year.
- Other Non-Current Assets was little changed at $215000.0 in Q1 2026 per BIOA's latest filing, from $216000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $3.3 million in Q4 2023 and troughed at $215000.0 in Q1 2026.
- A 4-year average of $667714.3 and a median of $237000.0 in 2025 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 92.73% in 2024, then slipped 10.0% in 2025.
- Over 4 years, Other Non-Current Assets stood at $3.3 million in 2023, then plunged by 92.73% to $240000.0 in 2024, then declined by 10.0% to $216000.0 in 2025, then dropped by 0.46% to $215000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $215000.0, $216000.0, and $227000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 13.00 Mn |
| 10 | BioAge Labs | 436.28 Mn | 436.28 Mn | -14.23 Mn | 208,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 208,000.00 |
| Mar 31, 2026 | 215,000.00 |
| Dec 31, 2025 | 216,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 3.30 Mn |